Cost-effectiveness of thrombolytic therapy for acute myocardial infarction. [electronic resource]
- The Annals of pharmacotherapy May 1997
- 596-603 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1060-0280
10.1177/106002809703100515 doi
Acute Disease Aged Cost-Benefit Analysis Decision Trees Fibrinolytic Agents--economics Humans Middle Aged Myocardial Infarction--economics Quality of Life Recurrence Survival Analysis Thrombolytic Therapy--economics Treatment Outcome